atazanavir sulfate has been researched along with fibrinogen in 1 studies
| Studies (atazanavir sulfate) | Trials (atazanavir sulfate) | Recent Studies (post-2010) (atazanavir sulfate) | Studies (fibrinogen) | Trials (fibrinogen) | Recent Studies (post-2010) (fibrinogen) |
|---|---|---|---|---|---|
| 1,102 | 246 | 590 | 34,477 | 1,707 | 7,083 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carman, T; Hileman, C; Labbato, DE; Longenecker, C; McComsey, G; Milne, G; Storer, Nj; White, C | 1 |
1 other study(ies) available for atazanavir sulfate and fibrinogen
| Article | Year |
|---|---|
Relationship between total bilirubin and endothelial function, inflammation and oxidative stress in HIV-infected adults on stable antiretroviral therapy.
Topics: Adult; Atazanavir Sulfate; Bilirubin; Blood Flow Velocity; Brachial Artery; C-Reactive Protein; Cell Adhesion Molecules; Cross-Sectional Studies; Endothelium, Vascular; F2-Isoprostanes; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; HIV Protease Inhibitors; HIV Seropositivity; Humans; Inflammation; Interleukin-6; Male; Middle Aged; Oligopeptides; Oxidative Stress; Pyridines; Retrospective Studies; Tumor Necrosis Factor-alpha; Vasodilation | 2012 |